These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 21853301)
1. Upregulation of B7-H1 expression is associated with macrophage infiltration in hepatocellular carcinomas. Chen J; Li G; Meng H; Fan Y; Song Y; Wang S; Zhu F; Guo C; Zhang L; Shi Y Cancer Immunol Immunother; 2012 Jan; 61(1):101-8. PubMed ID: 21853301 [TBL] [Abstract][Full Text] [Related]
2. Preferential Expression of Programmed Death Ligand 1 Protein in Tumor-Associated Macrophages and Its Potential Role in Immunotherapy for Hepatocellular Carcinoma. Park DJ; Sung PS; Lee GW; Cho S; Kim SM; Kang BY; Hur W; Yang H; Lee SK; Lee SH; Jung ES; Seo CH; Ahn J; Choi HJ; You YK; Jang JW; Bae SH; Choi JY; Yoon SK Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946835 [TBL] [Abstract][Full Text] [Related]
3. IL-1β-Induced Elevation of Solute Carrier Family 7 Member 11 Promotes Hepatocellular Carcinoma Metastasis Through Up-regulating Programmed Death Ligand 1 and Colony-Stimulating Factor 1. He Q; Liu M; Huang W; Chen X; Zhang B; Zhang T; Wang Y; Liu D; Xie M; Ji X; Sun M; Tian D; Xia L Hepatology; 2021 Dec; 74(6):3174-3193. PubMed ID: 34288020 [TBL] [Abstract][Full Text] [Related]
4. Liver fibrosis promotes immune escape in hepatocellular carcinoma via GOLM1-mediated PD-L1 upregulation. Ke MY; Xu T; Fang Y; Ye YP; Li ZJ; Ren FG; Lu SY; Zhang XF; Wu RQ; Lv Y; Dong J Cancer Lett; 2021 Aug; 513():14-25. PubMed ID: 33992711 [TBL] [Abstract][Full Text] [Related]
5. Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade. Zhu Y; Yang J; Xu D; Gao XM; Zhang Z; Hsu JL; Li CW; Lim SO; Sheng YY; Zhang Y; Li JH; Luo Q; Zheng Y; Zhao Y; Lu L; Jia HL; Hung MC; Dong QZ; Qin LX Gut; 2019 Sep; 68(9):1653-1666. PubMed ID: 30902885 [TBL] [Abstract][Full Text] [Related]
6. Cross-talk between TNF-α and IFN-γ signaling in induction of B7-H1 expression in hepatocellular carcinoma cells. Li N; Wang J; Zhang N; Zhuang M; Zong Z; Zou J; Li G; Wang X; Zhou H; Zhang L; Shi Y Cancer Immunol Immunother; 2018 Feb; 67(2):271-283. PubMed ID: 29090321 [TBL] [Abstract][Full Text] [Related]
7. TGF-β1-Induced SOX18 Elevation Promotes Hepatocellular Carcinoma Progression and Metastasis Through Transcriptionally Upregulating PD-L1 and CXCL12. Chen J; Feng W; Sun M; Huang W; Wang G; Chen X; Yin Y; Chen X; Zhang B; Nie Y; Fan D; Wu K; Xia L Gastroenterology; 2024 Jul; 167(2):264-280. PubMed ID: 38417530 [TBL] [Abstract][Full Text] [Related]
8. Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7-H1/programmed death-1 interactions. Wu K; Kryczek I; Chen L; Zou W; Welling TH Cancer Res; 2009 Oct; 69(20):8067-75. PubMed ID: 19826049 [TBL] [Abstract][Full Text] [Related]
9. Immune checkpoint molecules are regulated by transforming growth factor (TGF)- Shrestha R; Bridle KR; Crawford DHG; Jayachandran A Int J Med Sci; 2021; 18(12):2466-2479. PubMed ID: 34104078 [TBL] [Abstract][Full Text] [Related]
10. FAT10 induces immune suppression by upregulating PD-L1 expression in hepatocellular carcinoma. Wang Q; Tan W; Zhang Z; Chen Q; Xie Z; Yang L; Tang C; Zhuang H; Wang B; Jiang J; Ma X; Wang W; Hua Y; Shang C; Chen Y Apoptosis; 2024 Oct; 29(9-10):1529-1545. PubMed ID: 38824477 [TBL] [Abstract][Full Text] [Related]
12. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells. Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303 [TBL] [Abstract][Full Text] [Related]
13. Glycolytic activation of peritumoral monocytes fosters immune privilege via the PFKFB3-PD-L1 axis in human hepatocellular carcinoma. Chen DP; Ning WR; Jiang ZZ; Peng ZP; Zhu LY; Zhuang SM; Kuang DM; Zheng L; Wu Y J Hepatol; 2019 Aug; 71(2):333-343. PubMed ID: 31071366 [TBL] [Abstract][Full Text] [Related]
14. IL-12 regulates B7-H1 expression in ovarian cancer-associated macrophages by effects on NF-κB signalling. Xiong HY; Ma TT; Wu BT; Lin Y; Tu ZG Asian Pac J Cancer Prev; 2014; 15(14):5767-72. PubMed ID: 25081699 [TBL] [Abstract][Full Text] [Related]
15. Characterization of the Immune Microenvironment in Hepatocellular Carcinoma. Yarchoan M; Xing D; Luan L; Xu H; Sharma RB; Popovic A; Pawlik TM; Kim AK; Zhu Q; Jaffee EM; Taube JM; Anders RA Clin Cancer Res; 2017 Dec; 23(23):7333-7339. PubMed ID: 28928158 [No Abstract] [Full Text] [Related]
16. IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma. Zhang W; Liu Y; Yan Z; Yang H; Sun W; Yao Y; Chen Y; Jiang R J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581055 [TBL] [Abstract][Full Text] [Related]
17. Expression of tumor-associated macrophages and PD-L1 in patients with hepatocellular carcinoma and construction of a prognostic model. Kong P; Yang H; Tong Q; Dong X; Yi MA; Yan D J Cancer Res Clin Oncol; 2023 Sep; 149(12):10685-10700. PubMed ID: 37306737 [TBL] [Abstract][Full Text] [Related]
18. Amphotericin B suppresses M2 phenotypes and B7-H1 expression in macrophages to prevent Raji cell proliferation. Zhang J; Cao D; Yu S; Chen L; Wei D; Shen C; Zhuang L; Wang Q; Xu X; Tong Y BMC Cancer; 2018 Apr; 18(1):467. PubMed ID: 29695237 [TBL] [Abstract][Full Text] [Related]
19. Interferon Gamma-Induced Interferon Regulatory Factor 1 Activates Transcription of HHLA2 and Induces Immune Escape of Hepatocellular Carcinoma Cells. Wang R; Guo H; Tang X; Zhang T; Liu Y; Zhang C; Yu H; Li Y Inflammation; 2022 Feb; 45(1):308-330. PubMed ID: 34536158 [TBL] [Abstract][Full Text] [Related]
20. Sarcomatoid hepatocellular carcinoma is distinct from ordinary hepatocellular carcinoma: Clinicopathologic, transcriptomic and immunologic analyses. Morisue R; Kojima M; Suzuki T; Nakatsura T; Ojima H; Watanabe R; Sugimoto M; Kobayashi S; Takahashi S; Konishi M; Ishii G; Gotohda N; Fujiwara T; Ochiai A Int J Cancer; 2021 Aug; 149(3):546-560. PubMed ID: 33662146 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]